Sulfobutyl Ether Beta Cyclodextrin Sodium Salt, Brand Name : zhiyuan

Key product advantages

1. Improved solubility and improved formula

2. Allow the formation of water-insoluble APIs in all dosage forms, including oral, injection, ophthalmology, nose, local and inhaled products

4. Tasteless and odourless -- the taste masking of the mouth, nose and inhaled preparations

5. Less stimulation at injection site

6. Improve bioavailability and delivery efficiency

7. Bioavailability is better than that of solutions using nanoparticles and solvent systems

8. Low dose API is allowed (i.e., the potential of dose saving)

Quality assurance of our products: ISO\DMF clinical approval,

With well-defined impurity profile and long-term stability,

The company has obtained the drug production license and passed ISO9000 quality system certification. Its hydroxypropyl betacyclic dextrin has been registered and approved, and its Sulfobutyl Ether beta cyclodextrin Sodium salt has been approved clinically.

Both hydroxypropyl betacytodextrin and Sulfobutyl Ether beta cyclodextrin Sodium salt have been registered with the FDA and obtained DMF registration number.

Products have independent intellectual property rights, sold to Europe, the United States, Japan, Korea, India, Pakistan, South America, the Middle East and other countries and regions, many times received customer audit and received great recognition and praise

Sulfobutyl Ether beta cyclodextrin Sodium salt,cyclodextrin,182410-00-0

Our representative products include:

 Sulfobutyl Ether beta cyclodextrin Sodium salt（CAS:182410-00-0）

Hydroxypropyl beta cyclodextrin （CAS:128446-35-5）

α-cyclodextrin （CAS:10016-20-3）

β-cyclodextrin（CAS:7585-39-9）

gamma-cyclodextrin（CAS:17465-86-0）

Piroxicam beta Cyclodextrin（CAS:96684-39-8）